Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
about
A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 geneSpecific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule levelMolecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer developmentDNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancersEpigenetic inactivation of CHFR in human tumorsCpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2Methods for analyzing the role of DNA methylation and chromatin structure in regulating T lymphocyte gene expressionMethylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.Epigenetics of cervical cancer. An overview and therapeutic perspectivesThe emerging role of Twist proteins in hematopoietic cells and hematological malignanciesMeCP2: the chromatin connection and beyondGene reactivation by 5-aza-2'-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regionsThe major form of MeCP2 has a novel N-terminus generated by alternative splicingConstitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting.A structural split in the human genome.CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome.Whole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition.DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.HLA-G gene repression is reversed by demethylationMethyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation.DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma.Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.Nutrients intake is associated with DNA methylation of candidate inflammatory genes in a population of obese subjects.Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A).Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island.Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?The study of aberrant methylation in cancer via restriction landmark genomic scanning.An overview of the analysis of DNA methylation in mammalian genomes.A role for poly(ADP-ribosyl)ation in DNA methylation.Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?Epigenomics and ovarian carcinoma.The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapyThe silence of the genes: epigenetic disturbances in haematopoietic malignancies.DNA Methylation Variation Trends during the Embryonic Development of ChickenA new dimethyl sulfoxide-based method for gene promoter methylation detection
P2860
Q21142628-40D9B0D9-A8E5-4CCB-93B9-08D511DD2705Q24533103-134387F6-1A6B-463E-A2EE-83AC888924F3Q24535523-980D8709-C68B-4708-ACFB-9FA5BCF49C14Q24616554-6E7EA5F0-68A8-4616-A503-72B49046EB10Q24642645-04269C33-3E6E-4E51-8C1A-BBA0F2272532Q24670147-5064CE21-D3CE-4CCB-9E46-BBE5A312B847Q24684224-980650DD-7460-4F86-911C-19289984D65AQ24794264-285F5E3F-DE23-4DB2-9C70-997C101376A3Q24794569-45EE5B84-059D-467D-861C-16767927201BQ24812104-01CBA416-892F-4B4C-AD54-A9001FCD8376Q26822434-D90ABEB3-9171-4B64-A00C-A7AEC32E8998Q28256925-392347CE-9587-4E07-96DF-B3B600352F84Q28481765-4B70532C-9E67-44BC-AF39-5D9D6A465EEAQ28511496-844AED95-DE0A-474B-B9EF-4C8A1859F87DQ33258474-EC37C016-B38B-4273-81FA-61ADF2D76E35Q33290437-A5840E3B-E37A-411D-9004-3A0B98F3F946Q33337445-7F272AAA-840D-402B-9256-CAEEB5EFCD7BQ33610854-8FCE32DD-A8D3-4DCB-8DE9-03DA4C5975ADQ33905153-2BE010EC-F139-4E25-8733-5B3141498CA9Q33938990-54B0C5CD-4453-490A-9973-5CF98C5D44C2Q33952447-B958B008-AC78-4226-A25F-7985A4704A85Q33963997-8B5EE6E9-B367-497C-BD98-D9BAE9CC758FQ34053125-0310C5A4-854D-48EC-9CE4-4B68F4B37B26Q34101643-F588708B-FAF4-41A2-BFC3-A2A43CCCDDC0Q34220062-B50E157C-F97E-4855-907A-0D3CCEC30011Q34329052-36331F89-BE96-4F0F-B933-569E83FB5A5EQ34411790-BDB3DB49-D6EE-44BF-A2CD-75EBBFC6DD63Q34550062-D3E8DDCD-91F7-40F3-992F-C192B2FAA1A4Q34609368-DDD6B781-E3B3-45D1-B0FD-FCA468396F6CQ34712569-09FE3624-FFB8-4418-86E5-953930E03E37Q34770530-FA62D213-5230-474C-A082-05D8EF0EC55CQ34770561-BBAADB9A-9683-495F-9378-4C69AC3853C5Q34835441-706A61CF-5A26-4677-8C3D-AB1216912EEBQ35191562-3F89D413-91B2-4A98-AED5-65096CEDC1BBQ35217405-7D93159F-20B6-4A89-866D-B8B3FAB31E1BQ35636575-EF2EE088-4E41-4596-B533-713A7541FFFCQ35847845-1EE6F81A-C35E-4AEB-9008-186A6532BDA8Q36066276-1D4C5A8B-2D12-45FE-BC46-FB26F5F49514Q36083008-0409CEDD-70AB-48FF-81A6-544D3DB3C1ABQ36103447-49CEEEC8-B9E5-4376-91D6-003C6223A802
P2860
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Altered chromatin structure as ...... MeCP2 binding and acetylation.
@ast
Altered chromatin structure as ...... MeCP2 binding and acetylation.
@en
type
label
Altered chromatin structure as ...... MeCP2 binding and acetylation.
@ast
Altered chromatin structure as ...... MeCP2 binding and acetylation.
@en
prefLabel
Altered chromatin structure as ...... MeCP2 binding and acetylation.
@ast
Altered chromatin structure as ...... MeCP2 binding and acetylation.
@en
P2093
P2860
P356
P1476
Altered chromatin structure as ...... MeCP2 binding and acetylation.
@en
P2093
C T Nguyen
F A Gonzales
P2860
P304
P356
10.1093/NAR/29.22.4598
P407
P577
2001-11-01T00:00:00Z